What you need to know on Tuesday, February 16:
Optimism maintained the greenback under pressure against all major rivals but the JPY. The upbeat sentiment was backed by hopes that US Congress will speed up a stimulus bill now that they acquitted former US President Donald Trump on his second impeachment.
China and the US markets were closed amid local holidays, but US futures rose to fresh record-highs. Chinese holidays will continue for most of this week.
Major pairs saw little action with the EUR/USD pair unchanged for a fourth consecutive day. GBP/USD continued to grind higher and reclaimed the 1.3900 threshold, amid the broad dollar’s weakness and the absence of UK macroeconomic news that could hit the pound. Commodity-linked currencies were also up against their American rival.
Coronavirus: Optimism overshadowed concerns related to new strains, as those countries leading vaccine immunization report encouraging results. In Israel, the number of new cases, severe illness and deaths keeps falling among those who received two Pfizer’s shots. Also, the UK has reached 15 million people vaccinated threshold, reporting under 10,000 new daily cases for the first time since October last year.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.